VOYA Investment Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
VOYA Investment Management's BEAM Position: Q1 2026 in Review
VOYA Investment Management reduced its Beam Therapeutics (BEAM) stake by 26% in Q1 2026, selling an estimated $405K and leaving 41,493 shares worth $989K. The position accounts for ﹤0.01% of the portfolio, ranked #1453.
VOYA Investment Management first reported a position in BEAM in Q3 2020 and has held it in 23 quarters since. The position peaked at $12.9M in Q3 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.
- VOYA Investment Management held 41,493 shares of Beam Therapeutics worth $989K as of Q1 2026.
- VOYA Investment Management sold 14,598 Beam Therapeutics shares in Q1 2026, an estimated $405K.
- Beam Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1453 holding.
- VOYA Investment Management first reported a position in Beam Therapeutics in Q3 2020 and has held it in 23 quarters since.
- VOYA Investment Management's Beam Therapeutics position peaked at $12.9M in Q3 2021.
- 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.
Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.